Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Coronary Crossing System in Patients With Coronary Chronic Total Occlusions

NCT: NCT05813704 · COMPLETED

NCT IDNCT05813704
StatusCOMPLETED
Start Date2023-11-07
Completion2024-08-19
SponsorShanghai MicroPort Rhythm MedTech Co., Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective and multicenter clinical investigation aiming to evaluate the safety and effectiveness of coronary crossing system for the treatment of patients with coronary chronic total occlusions.

Frequently Asked Questions

What is Coronary Crossing System in Patients With Coronary Chronic Total Occlusions?

Coronary Crossing System in Patients With Coronary Chronic Total Occlusions is a clinical trial registered under NCT05813704. Current status: COMPLETED.

What is the status of NCT05813704?

The current status of NCT05813704 (Coronary Crossing System in Patients With Coronary Chronic Total Occlusions) is: COMPLETED.

When did Coronary Crossing System in Patients With Coronary Chronic Total Occlusions start?

Coronary Crossing System in Patients With Coronary Chronic Total Occlusions started on 2023-11-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.